|
References
1. Baldessarini RJ. American biological psychiatry
and psychopharmacology, 1944-1994. In: Menninger RW, Nemiah JC,
editors. American psychiatry after World War II (1944-1994). Washington
(DC): American Psychiatric Press; 2000. p 371–412.
2. Stoll AL, Tohen M, Baldessarini RJ, Goodwin DC, Stein S, Katz
S, and others Shifts in diagnostic frequencies of schizophrenia
and major affective disorders at six North American psychiatric
hospitals, 1972-1988. Am J Psychiatry 1993;150:1668–73.
3. Goodwin FK, Jamison KR. Manic Depressive Illness. New York: Oxford
University Press; 1990.
4. Regier DA, Kaelber CT. The epidemiologic catchment area (ECA)
program: studying the prevalence and incidence of psychopathology.
In: Tsuang MT, Tohen M, Zahner GEP, editors. Textbook in psychiatric
epidemiology. New York: John Wiley; 1995. p. 133–57.
5. Weissman MM, Leaf PJ, Tischler GL, Blazer DG, Karno M, Bruce
ML, and others Affective disorders in 5 US communities [published
erratum appears in Psychol Med 1988;18:following 792]. Psychol Med
1988;18:141–53.
6. Robins LN, Helzer JE, Croughan J, Ratcliff KS. National Institute
of Mental Health diagnostic interview. Arch Gen Psychiatry 1981;38:381–9.
7. Helzer JE, Robins LN, McEnvoy LT, Spitznagel EL, Stoltzman RK,
Farmer A, and others A comparison of clinical and diagnostic interview
schedule diagnoses: Physician reexamination of lay-interviewed cases
in the general population. Arch Gen Psychiatry 1985;42:657–66.
8. Dohrenwend B. “The problem of validity in field studies
of psychological disorders” revisited. In: Tsuang M, Tohen
M, Zahner G, editors. Textbook in psychiatric epidemiology. New
York: Wiley-Liss; 1995. p 3–22.
9. Robins LN, Locke BZ, Regier DA. An overview of psychiatric disorders
in America. In: Robins LN, Regier DA, editors. Psychiatric disorders
in America. New York: Free Press; 1991. p 328–66.
10. Tsuang MT, Winokur G, Crowe RR. Morbidity risks of schizophrenia
and affective disorders among first degree relatives of patients
with schizophrenia, mania, depression, and surgical conditions.
Br J Psychiatry 1980;137:497 504.
11. Lish JD, Dime-Meenan S, Whybrow PC, Price RA, Hirschfeld RMA.
The National Depressive and Manic-depressive Association (NDMDA)
survey of bipolar members. J Affect Disord 1994;31:281–94.
12. Ghaemi SN, Hebben N, Stoll AL, Pope HG. Neuropsychological aspects
of lack of insight in bipolar disorder: a preliminary report. Psychiatry
Res 1996;65:113–20.
13. Ghaemi SN, Boiman EE, Goodwin FK. Diagnosing bipolar disorder
and the effect of antidepressants: a naturalistic study. J Clin
Psychiatry 2000;61:804–8.
14. Akiskal HS. The prevalent clinical spectrum of bipolar disorders:
beyond DSM-IV. J Clin Psychopharmacol 1996;16(Suppl 1):4S–14S.
15. Sprock J. Classification of schizoaffective disorder. Compr
Psychiatry 1988;29(1):55–71.
16. Michalakeas A, Skoutas C, Charalambous A, Peristeris A, Marinos
V, Keramari E, and others Insight in schizophrenia and mood disorders
and its relation to psychopathology. Acta Psychiatr Scand 1994;90(1):46–9.
17. Ghaemi SN, Stoll AL, Pope HG. Lack of insight in bipolar disorder:
The acute manic episode. J Nerv Ment Dis 1995;183:464–7.
18. Amador XA, Flaum M, Andreasen NC, Strauss DH, Yale SA, Clark
SC, and others Awareness of illness in schizophrenia and schizoaffective
and mood disorders. Arch Gen Psychiatry 1994;51:826–36.
19. Keitner GI, Solomon DA, Ryan CE, Miller IW, Mallinger A, Kupfer
DJ, and others Prodromal and residual symptoms in bipolar I disorder.
Compr Psychiatry 1996;37:362–7.
20. Akiskal HS, Djenderedjian AH, Rosenthal RH, Khani MK. Cyclothymic
disorder: validating criteria for inclusion in the bipolar affective
group. Am J Psychiatry 1977;134:1227–33.
21. Akiskal HS, Pinto O. The evolving bipolar spectrum. Prototypes
I, II, III, and IV. Psychiatr Clin North Am 1999;22:517–34.
22. Angst J. The emerging epidemiology of hypomania and bipolar
II disorder. J Affect Disord 1998;50:143–51.
23. Baldessarini RJ. A plea for the integrity of the bipolar concept.
Bipolar Disorders 2000;2(1):3–7.
24. Gershon ES, Guroff JJ. Information from relatives. Diagnosis
of affective disorders. Arch Gen Psychiatry 1984;41:173–80.
25. Klerman GL. The spectrum of mania. Compr Psychiatry 1981;22(1):11–20.
26. Akiskal HS, Walker P, Puzantian VR, King D, Rosenthal TL, Dranon
M. Bipolar outcome in the course of depressive illness. J Affect
Disord 1983;5:115–28.
27. Mitchell P, Parker G, Jamieson K, Wilhelm K, Hickie I, Brodaty
H, and others Are there any differences between bipolar and unipolar
melancholia? J Affect Disord 1992;25:97–106.
28. Bourgeois ML. The bipolar spectrum of depressions. In: Vieta
E, editor. Bipolar disorders: clinical and therapeutic progress.
Madrid: Panamericana; 2001. p 113–26.
29. Altshuler LL, Post RM, Leverich GS, Mikalauskas K, Rosoff A,
Ackerman L. Antidepressant-induced mania and cycle acceleration:
a controversy revisited. Am J Psychiatry 1995;152:1130–8.
30. Benazzi F. Antidepressant-associated hypomania in outpatient
depression: a 203-case study in private practice. J Affect Disord
1997;46(1):73–7.
31. Post R, Denicoff K, Leverich G, Frye M. Drug-induced switching
in bipolar disorder. CNS Drugs 1997;8:352–5.
32. Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W, Keller
M, and others Switching from ‘unipolar’ to bipolar II.
An 11-year prospective study of clinical and temperamental predictors
in 559 patients. Arch Gen Psychiatry 1995;52:114–23.
33. Hantouche EG, Akiskal HS, Lancrenon S, Allilaire J-F, Sechter
D, Azorin J-M, and others Systematic clinical methodology for validating
bipolar-II disorder: data in mid-stream from a French national multi-site
study. J Affect Disord 1998;50:163–73.
34. Agosti V, Stewart JW. Atypical and non-atypical subtypes of
depression: comparison of social functioning, symptoms, course of
illness, co-morbidity, and demographic features. J Affect Disord
2001;65(1):75–9.
35. Mitchell PB, Wilhelm K, Parker G, Austin M, Rutgers P, Malhi
GS. The clinical features of bipolar depression: a comparison with
matched major depressive disorder patients. J Clin Psychiatry 2001;62:212–6.
36. Akiskal HS, Bourgeois ML, Angst J, Post R, Moller H-J, Hirschfeld
RMA. Re-evaluating the prevalence of and diagnostic composition
within the broad clinical spectrum of bipolar disorders. J Affect
Disord 2000;59(Suppl):S5–S30.
37. Cassano GB, Dell’Osso L, Frank E, Miniati M, Fagiolini
A, Shear K, and others The bipolar spectrum: a clinical reality
in search of diagnostic criteria and an assessment methodology.
J Affect Disord 1999;54:319–28.
38. Bschor T, Canata B, Muller-Oerlinghausen B, Bauer M. Predictors
of response to lithium augmentation in TCA-resistant depression.
J Affect Disord 2001;64:261–5.
39. Sharma V. Loss of response to antidepressants and subsequent
refractoriness: diagnostic issues in a retrospective case series.
J Affect Disord 2001;64(1):99–106.
40. Prien RF, Klett CJ, Caffey EM. Lithium carbonate and imipramine
in prevention of affective episodes. Arch Gen Psychiatry 1973;29:420–5.
41. Wehr TA, Goodwin FK. Rapid cycling in manic-depressives induced
by tricyclic antidepressants. Arch Gen Psychiatry 1979;36:555–9.
42. Quitkin FM, Kane JM, Rifkin A, Ramos-Lorenzi JR, Nayak DV. Prophylactic
lithium carbonate with and without imipramine for bipolar 1 patients.
Arch Gen Psychiatry 1981;38:902–7.
43. Kane JM, Quitkin FM, Rifkin A, Ramos-Lorenzi JR, Nayak DD, Howard
A. Lithium carbonate and imipramine in the prophylaxis of unipolar
and bipolar II illness: a prospective, placebo-controlled comparison.
Arch Gen Psychiatry 1982;39:1065–9.
44. Prien RF, Kupfer DJ, Mansky PA, Small JG, Tuason VB, Voss CB,
and others Drug therapy in the prevention of recurrences in unipolar
and bipolar affective disorders: A report of the NIMH collaborative
study group comparing lithium carbonate, imipramine, and a lithium
carbonate-imipramine combination. Arch Gen Psychiatry 1984;41:1096–1104.
45. Amsterdam JD, Garcia-Espana F, Fawcett J, Quitkin FM, Reimherr
FW, Rosenbaum JR, and others Efficacy and safety of fluoxetine in
treating bipolar II major depressive episode. J Clin Psychopharmacol
1998;18:435–40.
46. Sachs GS, Lafer B, Stoll AL, Banov M, Thibault AB, Tohen M,
and others A double-blind trial of bupropion versus desiprimine
for bipolar depression. J Clin Psychiatry 1994;55:391–3.
47. Wehr TA, Sack DA, Rosenthal NE, Cowdry RW. Rapid cycling affective
disorder: contributing factors and treatment responses in 51 patients.
Am J Psychiatry 1988;145:179–84.
48. Kukopulos A, Reginaldi P, Laddomada G, Floris G, Serra G, Tondo
L. Course of the manic-depressive cycle and changes caused by treatments.
Pharmakopsychiatrie 1980;13:156–67.
49. Kukopulos A. The role of antidepressant treatments in rapid-cycling
(abstract). In: Proceedings of the symposium at the second International
Conference on Bipolar Disorder; 1997 June 19–21; Pittsburgh,
PA.
50. Kukopulos A, Caliari B, Tundo A, Minnai G, Floris G, Reginaldi
D, and others Rapid cyclers, temperament, and antidepressants. Compr
Psychiatry 1983;24:249–58.
51. Turvey CL, Coryell WH, Solomon DA, Leon AC, Endicott J, Keller
MB, and others Long-term prognosis of bipolar I disorder. Acta Psychiatr
Scand 1999;99:110–19.
52. Sachs GS, Printz DJ, Kahn DA, Carpenter D, Docherty JP. The
expert consensus guideline series: medication treatment of bipolar
disorder. Postgrad Med 2000; Apr:1–104.
53. Altshuler LL, Kiriakos L, Calcagno J, Goodman R, Gitlin M, Frye
M, and others The impact of antidepressant discontinuation versus
antidepressant continuation on 1-year risk for relapse of bipolar
depression: a retrospective chart review. J Clin Psychiatry 2001;62:612–6.
54. Post RM, Altshuder LL, Frye MA, Suppes T, Rush AJ, Keck PE,
and others. An update on the Stanley Foundation Bipolar Network
(SFBN). Bipolar Disorders 2001;3 (Suppl 1):13–4.
55. Ghaemi SN, Goodwin FK. Long-term naturalistic treatment of depressive
symptoms in bipolar illness with divalproex versus lithium in the
setting of minimal antidepressant use. J Affect Disorders 2001;65:281–7.
56. Goodwin FK, Ghaemi SN. An introduction to and history of affective
disorders. In: Gelder MG, Lopez-Ibor JJ, Andreasen NC, editors.
New Oxford Textbook of Psychiatry. New York: Oxford University Press;
2000. p 677–82.
57. Ghaemi SN, Ko JY, Goodwin FK. The bipolar spectrum and the antidepressant
view of the world. Journal of Psychiatric Practice 2001;7:287–97.
58. Spitzer R, Endicott J, Robins E. Research diagnostic criteria
for a selected group of functional disorders 2nd ed. New York: New
York State Psychiatric Institute; 1975.
59. Ghaemi SN, Lenox ML, Baldessarini RJ. Efficacy and safety of
antidepressants in long-term treatment of bipolar disorder. J Clin
Psychiatry 2001;62:565–9.
--------------------------------------------------------------------------------
Manuscript received and accepted February 2002.
1 Director, Bipolar Disorder Research Program,
Cambridge Hospital, Cambridge, Massachusetts; Assistant Professor
of Psychiatry, Harvard Medical School, Boston, Massachusetts.
2 Research Coordinator, Bipolar Disorder
Research Program, Cambridge Hospital, Cambridge, Massachusetts;
Associate in Psychiatry, Harvard Medical School, Boston, Massachusetts.
3 Director, Center on Neuroscience, Medical
Progress, and Society; Professor, Department of Psychiatry and Behavioral
Sciences, George Washington University, Washington, DC.
Address for correspondence: Dr SN Ghaemi, Department of Psychiatry,
Cambridge Hospital, 1493 Cambridge Street, Cambridge, MA 02139
E-mail: ghaemi@hms.harvard.edu
|
